Aimee Lenar Biography and Net Worth

Insider of Bausch Health Cos

Aimee is President, U.S. Pharma. Aimee joined Bausch Health in July 2024 as Executive Vice President, U.S. Pharma, leading gastroenterology, neuroscience, generics, market access and commercial operations. In 2025, the dermatology business moved under Aimee’s leadership, followed by the addition of the dentistry business in 2026. Before joining Bausch Health, Aimee was Head of U.S. prescription medicine at Galderma, responsible for sales, marketing, market access and business analytics, overseeing both a portfolio of established prescription products and a new immunology asset. Prior to that role, Aimee held leadership roles at AbbVie and Allergan, most recently serving as Vice President and General Manager of Neuroscience. Earlier, Aimee was Vice President of gastroenterology at AbbVie for more than five years.

Aimee brings a proven track record across multiple roles and deep experience in marketing and sales execution. Aimee holds a master’s degree in public health from Emory University.

What is Aimee J. Lenar's net worth?: The estimated net worth of Aimee J. Lenar is at least $2.15 million as of August 19th, 2026. Lenar owns 334,853 shares of Bausch Health Cos stock worth more than $2,153,105 as of August 21st. This net worth approximation does not reflect any other investments that Lenar may own. Learn More about Aimee J. Lenar's net worth.
How do I contact Aimee J. Lenar?: The corporate mailing address for Lenar and other Bausch Health Cos executives is 2150 ST. ELZEAR BLVD. WEST, LAVAL A8, H7L 4A8. Bausch Health Cos can also be reached via phone at (514) 744-6792 and via email at [email protected]. Learn More on Aimee J. Lenar's contact information.
Has Aimee J. Lenar been buying or selling shares of Bausch Health Cos?: In the last ninety days, Aimee J. Lenar has sold $258,893.81 in shares of Bausch Health Cos stock. Most recently, Aimee J. Lenar sold 36,827 shares of the business's stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $7.03, for a transaction totalling $258,893.81. Following the completion of the sale, the insider now directly owns 334,853 shares of the company's stock, valued at $2,354,016.59. Learn More on Aimee J. Lenar's trading history.
Who are Bausch Health Cos' active insiders?: Bausch Health Cos' insider roster includes Christina Ackermann (EVP), Seana Carson (EVP), Richard DeSchutter (Director), Sam Eldessouky (CFO), Joseph Gordon (Insider), William Humphries (Insider), Frank Lee (Director), Aimee Lenar (Insider), Steven Miller (Director), John Paulson (Director), Robert Spurr (Insider), and Amy Wechsler (Director). Learn More on Bausch Health Cos' active insiders.
Are insiders buying or selling shares of Bausch Health Cos?: In the last year, insiders at the sold shares 2 times. They sold a total of 61,283 shares worth more than $391,689.89. The most recent insider tranaction occured on August, 19th when insider Aimee J Lenar sold 36,827 shares worth more than $258,893.81. Insiders at Bausch Health Cos own 20.7% of the company. Learn More about insider trades at Bausch Health Cos.
Information on this page was last updated on 8/19/2026.

Aimee J. Lenar Insider Trading History at Bausch Health Cos

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/19/2026	Sell	36,827	$7.03	$258,893.81	334,853

Aimee J. Lenar Buying and Selling Activity at Bausch Health Cos

Bausch Health Cos Company Overview

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Today's Range

Now: $6.42

$6.38

$6.87

50 Day Range

MA: $5.33

$4.43

$7.01

2 Week Range

Now: $6.42

$4.33

$8.00

Volume

3,969,449 shs

Average Volume

2,550,462 shs

Market Capitalization

$2.40 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.38